AVEO Oncology
AVEO
#7099
Rank
ยฃ0.39 B
Marketcap
ยฃ11.26
Share price
0.00%
Change (1 day)
159.33%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : ยฃ54.33 Million

According to AVEO Oncology 's latest financial reports the company's total liabilities are ยฃ54.33 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31ยฃ44.05 M89.94%
2020-12-31ยฃ23.19 M-14.93%
2019-12-31ยฃ27.26 M-37.26%
2018-12-31ยฃ43.45 M-35.43%
2017-12-31ยฃ67.3 M184.33%
2016-12-31ยฃ23.67 M50.46%
2015-12-31ยฃ15.73 M-51.07%
2014-12-31ยฃ32.15 M-30.59%
2013-12-31ยฃ46.32 M-15.43%
2012-12-31ยฃ54.77 M19.05%
2011-12-31ยฃ46 M-10.41%
2010-12-31ยฃ51.35 M15.47%
2009-12-31ยฃ44.47 M-61.38%
2008-12-31ยฃ0.11 B37.72%
2007-12-31ยฃ83.61 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
ยฃ8.25 B 15,095.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ6.91 B 12,625.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
ยฃ17.01 M-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.76 B 108,051.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ68.37 B 125,728.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ60.44 B 111,136.67%๐Ÿ‡บ๐Ÿ‡ธ USA